Cortical Integrative Therapy in Smith-Lemli-Opitz Syndrome


Anstey A.V., Ryan A., Rhodes L.E., Charman C.R., Arlett C.F., Tyrrell R.M., Taylor C.R., Pearse A.D. “Characterization of photosensitivity in the Smith-Lemli-Opitz syndrome: a new congenital photosensitivity syndrome.” Br J Dermatology. 1999 Sep; 141 (3): 406-14.

Anstey A.V., Taylor C.R. “Photosensitivity in the Smith-Lemli-Opitz syndrome: the US experience of a new congenital photosensitivity syndrome.” J Am. Acad. Dermatology. 1999 Jul; 41(1): 121-3.

Antoniades K., Peonidis A., Pehlivanidis C., Kavadia S., Panagiotidis P. “Craniofacial manifestations of Smith-Lemli-Opitz syndrome: case report.” Int J Oral Maxillofac Surg. 1994 Dec 23 (6 Pt 1): 363-5.

Atchaneeyasakul L.O., Linck L.M., Connor W.E., Weleber R.G., Steiner R.D. “Eye findings in 8 children and a spontaneously aborted fetus with RSH/Smith-Lemli-Opitz syndrome.” Am J Med. Genet. 1998 Dec 28; 80(5): 501-5.

Azurdia R.M., Anstey A.V., Rhodes L.E. “Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome.” Br J Dermatology. 2001 Jan; 144 (1): 143-5.

Beby-Defaux A., Maille L., Chabot S., Nassimi A., Oriot D., Agius G. “Fatal adenovirus type 7b infection in a child with Smith-Lemli-Opitz syndrome.” J Med Virol. 2001 Sep; 65 (1): 66-9.

Berensztein E., Torrado M., Belgorosky A., Rivarola M. “Smith-Lemli-Opitz syndrome: in vivo and in vitro study of testicular function in a prepubertal patient with ambiguous genitalia.” Acta. Paediatr. 1999 Nov; 88 (11):1229-32.

Bjorkhem I., Starck L., Andersson U., Lutjohann D., von Bahr S., Pikuleva I., Babiker A., Diczfalusy U. “Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol.” J Lipid Res. 2001 Mar; 42 (3): 366-71.

DeBrasi D., Esposito T., Rossi M., Parenti G., Sperandeo M.P., Zuppaldi A., Bardaro T., Ambruzzi M.A., Zelante L., Ciccodicola A., Sebastio G., D’Urso M., Andria G. “Smith-Lemli-Opitz syndrome: evidence of T93M as a common mutation of delta 7-sterol reductase in Italy and report of three novel mutations.” Eur J Hum. Genet. 1999 Dec; 7 (8): 937-40.

Elias E.R., Hansen R.M., Irons M., Quinn M.B., Fulton A.B. “Rod photoreceptor responses in children with Smith-Lemli-Opitz syndrome.” Arch Ophthalmol. 2003 Dec; 121 (12): 1738-43.

Elias E.R., Irons M.B., Hurley A.D., Tint G.S., Salen G. “Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS).” Am J Med Genet. 1997 Jan 31; 68 (3): 305-10.

Ginsburg C., Fokstuen S., Schinzel A. “The contribution of uniparental disomy to congenital development defects in children born to mothers at advanced childbearing age.” Am J Med. Genet. 2000 Dec 18; 95(5): 454-60.

Goldenberg A., Chevy F., Bernard C., Wolf C., Cormier-Daire V. “Clinical characteristics and diagnosis of Smith-Lemli-Opitz syndrome and tentative phenotype-genotype correlation: report of 45 cases.” Arch Pediatr. 2003 Jan; 10 (1): 4-10.

Haas D., Kelley R.I., Hoffmann G.F. “Inherited disorders of cholesterol biosynthesis.” Neuropediatrics. 2001 Jun; 32 (3): 113-22.

Haghiri N., Menget A., Laitier V., Fromentin C., Nocton F., Kalach N. “Smith-Lemli-Opitz syndrome” Arch Pediatr. 1999 May; 6 (5): 536-9.

Ibanez V., Montalvo J.A., Perez R., Centelles I., Tosca R., Sancho V. “Acute gastric volvulus secondary to asplenia in a child with Smith-Lemli-Opitz syndrome.” Cir Pediatr. 2001 Jul; 14 (3): 129-31.

Irons M., Elias E.R., Abuelo D., Bull M.J., Greene C.L., Johnson V.P., Keppen L., Schanen C., Tint G.S., Salen G. “Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial.” Am J Med Genet. 1997 Jan 31; 68 (3): 315-21.

Itokazu N., Ohba K., Sonoda T., Ohdo S. “Infantile spasms in monozygotic twins with Smith-Lemli-Opitz syndrome type I. No To Hattatsu.” 1992 Sep; 24 (5): 485-90.

Jira P.E., Wanders R.J., Smeitink J.A., De Jong J., Wevers R.A., Oostheim W., Tuerlings J.H., Hennekam R.C., Sengers R.C., Waterham H.R. “Novel mutations in the 7-dehydrocholesterol reductase gene of 13 patients with Smith-Lemli-Opitz syndrome.” Ann Hum Genet. 2001 May; 65 (Pt 3): 229-36.

Kelley R.L. “Inborn errors of cholesterol biosynthesis.” Adv. Pediatr. 2000; 47: 1-53.

Kelley R.L., Roessler E., Hennekam R.C., Feldman G.L., Kosaki K., Jones M.C., Palumbos J.C., Muenke M. “Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?” Am J Med. Genet. 1996 Dec 30; 66 (4): 478-84.

Koenig K., Scahill L., Teague B. “The challenge of providing continuity in the care of a disabled child: Smith-Lemli-Opitz syndrome.” Issues Ment Health Nurs. 2002 Sep; 23 (6): 641-8.

Krakowiak P.A., Nwokoro N.A., Wassif C.A., Battaile K.P., Nowaczyk M.J., Connor W.E., Maslen C., Steiner R.D., Porter F.D. “Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: polymerase chain reaction-based assays to simplify genotyping.” Am J Med. Genet. 2000 Sep 18; 94 (3): 214-27.

Kretzer F.L., Hittner H.M., Mehta R.S. “Ocular manifestations of the Smith-Lemli-Opitz syndrome.” Arch Opththalmol. 1981 Nov. 99 (11): 2000-6.

Langius F.A., Waterham H.R., Romeijn G.J., Oostheim W., de Barse M.M., Dorland L., Duran M., Beemer F.A., Wanders R.J. “Poll-The B.T. Identification of three patients with a very mild form of Smith-Lemli-Opitz syndrome.” Am J Med. Genet. 2003 Sep 15; 122A(1): 24-9.

Linck L.M., Lin D.S., Flavell D., Connor W.E., Steiner R.D. “Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome.” Am J Med Genet. 2000 Aug 28; 93 (5): 360-5.

Marion R.W., Alvarez L.A., Marans Z.S., Lantos G., Chitayat D. “Computed tomography of the brain in the Smith-Lemli-Opitz syndrome.” J Child Neurol. 1987 Jul; 2 (3): 198-200.

Merkens L.S., Connor W.E., Linck L.M., Lin D.S., Flavell D.P., Steiner R.D. “Effects of dietary cholesterol on plasma lipoproteins in Smith-Lemli-Opitz syndrome.” Pediatr. Res. 2004 Aug 19 [Epub ahead of print]

Mueller C., Patel S., Irons M., Antshel K., Salen G., Tint G.S., Bay C. “Normal cognition and behavior in a Smith-Lemli-Opitz syndrome patient who presented with Hirschsprung disease.” Am J Med Genet. 2003 Nov 15; 123A (1): 100-6.

Munoz-Calvo M.T., Cenal-Gonzalez M.J., Parra-Martinez I., Hervas-Olivares F., Nieto-Cuartero J.A., Lestache R.G. “Smith-Lemli-Opitz syndrome; endocrinologic study.” An Esp Pediatr. 1981 Nov; 15 (5): 498-502.

Nezarati M.M. Loeffler J., Yoon G., MacLaren L., Fung E., Snyder F., Utermann G., Graham G.E. “Novel mutation in the Delta-sterol reductase gene in three Lebanese sibs with Smith-Lemli-Opitz (RSH) syndrome.” Am J Med Genet. 2002 Jun 15; 110 (2): 103-8.

Nissinen M.J., Gylling H., Kaski M., Tammisto P., Mieskonen S., Ignatius J., Miettinen T.A. “Smith-Lemli-Opitz syndrome and other sterol disorders among Finns with developmental disabilities.” J Lab Clin Med. 2000 Dec; 136 (6): 457-67.

Nowaczyk M.J., Martin-Garcia D., Aquino-Perna A., Rodriguez-Vazquez M., McCaughey D., Eng B., Nakamura L.M., Waye J.S. “Founder effect for the T93M DHCR7 mutation in Smith-Lemli-Opitz syndrome.” Am J Med Genet. 2004 Mar 1; 125A (2): 173-6.

Nowaczyk M.J., Whelan D.T., Heshka T.W., Hill R.E. “Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation.” CMAJ. 1999 Jul 27; 161 (2): 165-70.

Nwokoro N.A., Mulvihill J.J. “Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz syndrome.” Am J Med Genet. 1997 Jan 31; 68 (3): 315-21.

Opitz J.M., de la Cruz F. “Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference.” Am J Med. Genet. 1994 May 1;50 (4): 326-38.

Pappu A.S., Steiner R.D., Connor S.L., Flavell D.P., Lin D.S., Hatcher L., Illingworth D.R., Connor W.E. “Feedback inhibition of the cholesterol biosynthetic pathway in patients with Smith-Lemli-Opitz syndrome as demonstrated by urinary mevalonate excretion.” J Lipid Res. 2002 Oct; 43 (10): 1661-9.

Patrono C., Rizzo C., Tessa A., Giannotti A., Borrelli P., Carrozzo R., Piemonte F., Bertini E., Dionisi-Vici C., Santorelli F.M. “Novel 7-DHCR mutation in a child with Smith-Lemli-Opitz syndrome.” Am J Med Genet. 2000 Mar 13; 91 (2): 138-40.

Porter F.D. “RSH/Smith-Lemli-Opitz syndrome: a multiple congenital anomaly/retardation syndrome due to inborn error of cholesterol biosynthesis.” Mol Genet. Metab. 2000 Sep-Oct; 71 (1-2): 163-74.

Salen G., Shefer S., Batta A.K., Tint G.S., Xu G., Honda A., Irons M., Elias E.R. “Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.” J Lipid Res. 1996 Jun; 37 (6): 1169-80.

Scalco F.B., Cruzes V.M., Vendramini R.C., Brunetti I.L., Moretti-Ferreira D. “Diagnosis of Smith-Lemli-Opitz syndrome by ultraviolet spectrophotometry.” Braz J Med Biol. Res. 2003 Oct; 36 (10): 1327-32.

Shackleton C., Roitman E., Guo L.W., Wilson W.K., Porter F.D. “Identification of 7 (8) and 8 (9) unsaturated adrenal steroid metabolites produced by patients with 7-deehydrosterol-delta7-reductase deficiency (Smith-Lemli-Opitz syndrome).” J Steroid Biochem Mol Biol. 2002 Oct; 82 (2-3): 225-32.

Sikora D.M., Ruggiero M., Petit-Kekel K., Merkens L.S., Connor W.E., Steiner R.D. “Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome.” J Pediatr. 2004 Jun; 144 (6): 783-91.

Starck L., Bjorkhem I., Ritzen E.M., Nilsson B.Y., von Dobeln U. “Beneficial effects of dietary supplementation in a disorder with defective synthesis of cholesterol. A case report of a girl with Smith-Lemli-Opitz syndrome, polyneuropathy, and precocious puberty.” Acta. Paediatr. 1999 Jul; 88 (7): 729-33.

Starck L., Bjorkhem I., Lund E., von Dobeln U. “New possibilities for children with Smith-Lemli-Opitz syndrome. A cholesterol synthesis defect discovered. Lakartidningen.” 1995 Sep 13; 92 (37): 3325-6, 3329.

Starck L., Lovgren A. “Diagnosis of Smith-Lemli-Opitz syndrome from stored filter paper blood specimens.” Arch Dis Child. 2000 Jun; 82 (6): 490-2.

Steiner R.D., Linck L.M., Flavell D.P., Lin D.S., Connor W.E. “Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production.” J Lipid Res. 2000 Sep; 41 (9): 1437-47.

Tierney E., Nwokoro N.A., Porter F.D., Freund L.S., Ghuman J.K., Kelley R.I. “Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome.” Am J Med Genet. 2001 Jan 15; 98 (2): 191-200.

Tint G.S., Salen G., Batta A.K., Shefer S., Irons M., Elias E.R., Abuelo D.N., Johnson V.P., Lambert M., Lutz R. et al. “Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome.” J Pediatr. 1995 Jul; 127 (1): 82-7.

Tint G.S., Irons M., Elias E.R., Batta A.K., Frieden R., Chen T.S., Salen G. “Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome.” N Engl J Med. 1994 Jan 13; 330 (2): 107-13.

Tzouvelekis G., Antoniades K., Batma A., Nanas C. “Smith-Lemli-Opitz syndrome in female, monozygotic twins.” Clin Genet. 1991 Sep; 40 (3): 229-32.

Wassif C.A., Maslen C., Kachilele-Linjewile S., Lin D., Linck L.M., Connor W.E., Steiner R.D., Porter F.D. “Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.” Am J Hum Genet. 1998 Jul; 63 (1): 55-62.

Witsch-Baumgartner M., Fitzky B.U., Ogorelkova M., Kraft H.G., Moebius F.F., Glossmann H., Seedorf U., Gillessen-Kaesbach G., Hoffmann G.F., Clayton P., Kelley R.I., Utermann G. “Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.” Am J Hum Genet. 2000 Feb; 66 (2): 402-12.

Yu H., Lee M.H., Starck L., Elias E.R., Irons M., Salen G., Patel S.B., Tint G.S. “Spectrum of Delta (7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz syndrome.” Hum Mol Genet. 2000 May 22; 9 (9): 1385-91.